Influenza peptide ASNENMETM (H-2 Db)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
Influenza peptide ASNENMETM (H-2 Db)

Influenza peptide ASNENMETM (H-2 Db) is a single peptide for stimulation of T cells. The peptide from Influenza nucleoprotein is synthesized as it is presented by the MHC class I H-2 Db allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: ASNENMETM
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: H-2 Db

Podobne produkty

MHC I-Strep HLA-B*0702; EBV EBNA-3A (RPPIFIRRL)

MHC I-Strep HLA-B*0702; EBV EBNA-3A (RPPIFIRRL)

IBA Lifescience
Więcej
CD19 Fab-Strep, human

CD19 Fab-Strep, human

IBA Lifescience
Więcej
MHC I-Strep HLA-A*0201; Survivin (ELTLGEFLKL)

MHC I-Strep HLA-A*0201; Survivin (ELTLGEFLKL)

IBA Lifescience
Więcej